EGFR and neoplasm: Researchers found that the expression of HE4 decreased after inhibition of HIF1-α expression or treated with HIF1-α inhibitor in tumor cells; HE4 could co-immunoprecipitate and co-locate with EGFR, and the interaction between HE4 and EGFR was enhanced after upregulation of HE4 expression 42.